check_circleStudy Completed

Vaginal yeast infection

Activity and tolerability of BAY b 5097 10% vaginal cream in subjects with vaginal yeast infections

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

17 - 52 Years
  • -

  • -

Trial summary

Enrollment Goal
33
Trial Dates
March 1982 - August 1982
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

An open label study to assess the activity and tolerability of BAY b 5097 10% vaginal cream in subjects with vaginal yeast infections
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A